Cargando…
MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1
As a multikinase inhibitor, sorafenib is commonly used to treat patients with advanced hepatocellular carcinoma (HCC), however, acquired resistance to sorafenib is a major obstacle to the effectiveness of this treatment. Thus, in this study, we investigated the mechanisms underlying sorafenib resist...
Autores principales: | Dong, Zhe-bin, Wu, Heng-miao, He, Yi-cheng, Huang, Zhong-ting, Weng, Yi-hui, Li, Hong, Liang, Chao, Yu, Wei-ming, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748751/ https://www.ncbi.nlm.nih.gov/pubmed/35013144 http://dx.doi.org/10.1038/s41419-021-04491-0 |
Ejemplares similares
-
MiRNA 34-a regulate SIRT-1 and Foxo-1 expression in endometriosis
por: Rezk, Noha A., et al.
Publicado: (2021) -
Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
por: Garten, Antje, et al.
Publicado: (2019) -
Aralia taibaiensis Protects against I/R-Induced Brain Cell Injury through the Akt/SIRT1/FOXO3a Pathway
por: Duan, Jialin, et al.
Publicado: (2019) -
Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma
por: Liang, Chao, et al.
Publicado: (2020) -
Hypertrophy of Rat Skeletal Muscle Is Associated with Increased SIRT1/Akt/mTOR/S6 and Suppressed Sestrin2/SIRT3/FOXO1 Levels
por: Gombos, Zoltan, et al.
Publicado: (2021)